Longer Edoxaban May Benefit Cancer Patients With Distal DVT

The findings support extended anticoagulation in patients with active, ongoing cancer and isolated distal DVT, with caveats, including the need for individualized patient treatment decisions.

Related Keywords

Japan ,Madrid ,Spain ,Kyoto ,Teresa Lopez Fernandez ,Bristol Myers Squibb ,Pfizer ,Astrazeneca ,Paz University Hospital ,European Society Of Cardiology ,Myocardial Solutions ,Kyoto University ,Yugo Yamashita ,European Society ,Medscape Cardiology ,Bayer Healthcare ,Deep Venous Thrombosis Dvt ,Deep Vein Thrombosis ,Vt Deep Venous Thrombosis ,Thromboembolism ,Cancer ,Alignant Neoplasia ,Arcinoma ,Deep Venous Thrombosis Of The Upper Extremity ,Vt Of The Upper Extremity ,Deep Venous Thrombosis Of The Lower Extremity ,Vt Of The Lower Extremity ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,Metastasis ,Leukemia ,Hemorrhage ,Bleeding ,Clinical Guidelines ,